Novartis reinforces commitment to patient access, pricing a EUR 1.85 billion sustainability-linked bond
Novartis today announced the pricing of a EUR 1.85 billion sustainability-linked bond (SLB), reinforcing its commitment to ESG principles and the 2025 Patient Access Targets announced earlier this month.